AstraZeneca logo

Executive Medical Director Respiratory, Translational Science and Early Clinical Development

AstraZeneca

Cambridge, MAHybridPosted 2 days ago$331,873 - $497,810/year
Full TimeDirector & AboveClinical DevelopmentPharmaceutical
Original posting ↗

Summary

In the Respiratory Translational Sciences and Early Clinical Development Team, we are investigating the drivers of key respiratory and Th2 related diseases (atopic dermatitis, chronic rhinosinusitis), with access to pioneering science, innovative drug discovery approaches, and key collaborations with academic centers around the world. We are exploring a wide range of drug modalities – small molecules, biologics, oligonucleotides, and multispecifics – across multiple diseases with high unmet medical need.

Job description

Translational Sciences and Early Clinical Development (TSECD) is where science meets clinical drug development with a focus on delivering innovative, early-phase clinical studies (Phase 1 and 2a) and shaping our translational sciences strategy across the entire respiratory portfolio, from target selection through Phase 3. We are a diverse team, consisting of translational scientists, bioinformaticians, imaging scientists and physicians, who work together to define our early-phase strategies, design innovative early clinical trials, develop and validate new clinical endpoints, and translate scientific ideas to proof-of-concept studies in targeted patient populations.

The Role

AstraZeneca is looking for a dynamic Executive Medical Director to lead a respiratory clinical development team within our Respiratory R&D organization. We are searching for a motivated drug developer to shape the respiratory pipeline and provide clinical development leadership for cross-functional teams to support early phase clinical development and translational activities. In this role you will lead innovative clinical stage programs, and provide medical leadership for preclinical and clinical stage assets as well as translational science activities, across respiratory indications. You and your team will be responsible for the creation of overall clinical development plans and clinical study design, as well writing protocols, medical monitoring and ensuring timely execution of studies, all in close collaboration with relevant internal and external partners and clinical research organizations, and involvement in in-scope external innovation and business development activities. The successful candidate will thrive in a fast-paced, proactive can-do culture, be a highly effective internal and external team player as well as a terrific communicator and collaborator.

Responsibilities

  • Act as the accountable leader for the design, delivery and interpretation of clinical studies ensuring the ethical and scientific integrity of the plans, studies and the product in compliance with GCP
  • Provide impactful medical strategies and clinical expertise for key translational science activities (include external patient focused research activities and collaborations), as well as for our research, late-stage clinical development and commercial partners, including the development of therapeutic area strategy
  • Closely follow medical developments within assigned areas and disseminate new information within Clinical Development and wider organization, to transform trends and emerging data into agile clinical plans
  • Work closely and collaborate across early and late clinical development, partner functions and wider AZ organization to ensure timely design and delivery of high-quality clinical development plans
  • Represent respiratory early clinical development to external stakeholders, including investigators, key external experts, governmental/policy groups and community/patient advocacy groups
  • Act as a Medical Lead for regulatory communication and preparation of higher-level documents
  • Ensure internal and external peer review of potential study/program design
  • Support qualification of pharmacodynamic/disease markers for early assessment of efficacy
  • Provide clinical strategic input to in-licensing opportunities

Qualifications

  • Medical degree (MD, MBBS or equivalent) in a relevant scientific discipline, MD/PhD preferred
  • 7+ years of experience in clinical development with specialty training or clinical drug development experience in respiratory and/or Th2 related diseases, with background working in early clinical development (first in human through Ph2b)
  • Strong preference for experience in a large pharmaceutical environment
  • Significant experience in clinical and/or basic science research, that enables close collaboration with bioscientists and translational scientists on experimental design, data analysis and interpretation of results
  • Demonstrated track record in leading cross-functional teams and delivering results
  • Outstanding verbal and written communication skills, in addition to excellent organizational skills
  • Understanding of the entire drug development process, including clinical and non-clinical study design and execution
  • Deep understanding of clinical research methodology and biostatistics principles, to facilitate innovative and efficient clinical trial design, and clinical development plans with clear data-driven decision rules
  • Thorough command of FDA, MHRA and ICH GCP guidelines to ensure the appropriate conduct of clinical studies in the United States, Europe and rest of world
  • Attention to detail, internal drive to generate high-quality work, and sense of passion and urgency to achieve team and program goals
  • Demonstrated experience managing complex projects and working collaboratively with multiple stakeholders regarding new strategies to ensure consistent communication
  • Excellent analytical, problem-solving and strategic planning skills
  • Ability to thrive in a fast-paced environment

Requirements

  • Medical degree (MD, MBBS or equivalent) in a relevant scientific discipline
  • MD/PhD preferred
  • 7+ years of experience in clinical development
  • Specialty training or clinical drug development experience in respiratory and/or Th2 related diseases
  • Background working in early clinical development (first in human through Ph2b)
  • Strong preference for experience in a large pharmaceutical environment
  • Significant experience in clinical and/or basic science research
  • Demonstrated track record in leading cross-functional teams and delivering results
  • Outstanding verbal and written communication skills
  • Excellent organizational skills
  • Understanding of the entire drug development process, including clinical and non-clinical study design and execution
  • Deep understanding of clinical research methodology and biostatistics principles
  • Thorough command of FDA, MHRA and ICH GCP guidelines
  • Attention to detail and internal drive to generate high-quality work
  • Demonstrated experience managing complex projects and working collaboratively with multiple stakeholders
  • Excellent analytical, problem-solving and strategic planning skills
  • Ability to thrive in a fast-paced environment

Benefits

  • 401(k) Matching
  • Paid Vacation
  • Paid Holidays
  • Paid Leaves
  • Medical, Dental & Vision
  • Prescription Drug Coverage
  • Short-Term Incentive Bonus
  • Equity-Based Long-Term Incentive

Company overview

AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.